Cargando…
Cell death-related molecules and biomarkers for renal cell carcinoma targeted therapy
Renal cell carcinoma (RCC) is not sensitive to conventional radio- and chemotherapies and is at least partially resistant to impairments in cell death-related signaling pathways. The hallmarks of RCC formation include diverse signaling pathways, such as maintenance of proliferation, cell death resis...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708252/ https://www.ncbi.nlm.nih.gov/pubmed/31462894 http://dx.doi.org/10.1186/s12935-019-0939-2 |